Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal sequence receptor subunit 1 pseudogene 1 (SSR1P1)
- Target
- SSR1P1
- Molecular classification
- Other (Pseudogene)
01
Overview
Signal sequence receptor subunit 1 pseudogene 1 (SSR1P1) is a human pseudogene related to the functional SSR1 gene, which encodes a subunit of the signal sequence receptor in the endoplasmic reticulum. SSR1P1 itself is classified as a pseudogene, meaning it is a DNA sequence derived from a gene but is no longer capable of producing a functional protein, typically due to inactivating mutations or disruptions in its sequence. There is no evidence that SSR1P1 encodes a protein or participates in known cellular pathways, and it is not considered a therapeutic target or biomarker in current biomedical research. The presence of pseudogenes like SSR1P1 is common and they often serve as remnants of gene duplication or retrotransposition events in evolution.
- Other names
- Signal sequence receptor, alpha pseudogene 1SSR1P1
02
Mechanism of action
None (no known mechanisms relevant for drug targeting)
03
Biological functions
Other (no established function; as a pseudogene, it does not encode a functional protein product)
04
Disease associations
Other (there are no known direct disease associations for SSR1P1, as it is a non-coding pseudogene)
Beyond the preview
Go deeper on Signal sequence receptor subunit 1 pseudogene 1 (SSR1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Signal sequence receptor subunit 1 pseudogene 1 (SSR1P1).